Avanz Phleum pratense

DRUG2 trials

Sponsors

ALK-Abelló A/S

Conditions

Allergic Rhinoconjunctivitis

Phase 2

Avanz Phleum Pratense Maintenance Dose

CompletedNCT01438827

ALK-Abelló A/SAllergic Rhinoconjunctivitis

Start: 2011-09-30End: 2013-01-31Updated: 2014-01-22

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

CompletedNCT01454531

ALK-Abelló A/SAllergic Rhinoconjunctivitis

Start: 2011-06-30End: 2012-04-30Updated: 2015-03-06